| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vestibular Diseases | 11 | 2024 | 232 | 3.790 |
Why?
|
| Abnormalities, Multiple | 17 | 2024 | 1424 | 3.770 |
Why?
|
| Hematologic Diseases | 10 | 2024 | 498 | 2.840 |
Why?
|
| Neonatal Screening | 19 | 2017 | 620 | 2.430 |
Why?
|
| Histone Demethylases | 7 | 2023 | 328 | 2.110 |
Why?
|
| Fabry Disease | 10 | 2014 | 89 | 2.090 |
Why?
|
| Guanidinoacetate N-Methyltransferase | 10 | 2017 | 12 | 2.050 |
Why?
|
| Gaucher Disease | 11 | 2022 | 110 | 2.020 |
Why?
|
| Glycogen Storage Disease Type II | 9 | 2017 | 43 | 1.990 |
Why?
|
| Face | 10 | 2024 | 1029 | 1.900 |
Why?
|
| Creatine | 11 | 2017 | 424 | 1.810 |
Why?
|
| Tandem Mass Spectrometry | 17 | 2020 | 1197 | 1.740 |
Why?
|
| Neoplasm Proteins | 9 | 2024 | 3599 | 1.200 |
Why?
|
| Metabolism, Inborn Errors | 11 | 2020 | 291 | 1.190 |
Why?
|
| Congenital Disorders of Glycosylation | 4 | 2020 | 50 | 1.160 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 9 | 2017 | 283 | 1.130 |
Why?
|
| Mucopolysaccharidosis II | 6 | 2013 | 26 | 1.040 |
Why?
|
| Acidosis, Lactic | 2 | 2023 | 144 | 0.950 |
Why?
|
| Niemann-Pick Disease, Type C | 3 | 2023 | 57 | 0.940 |
Why?
|
| Carnitine | 9 | 2007 | 253 | 0.920 |
Why?
|
| Phenotype | 27 | 2023 | 16718 | 0.860 |
Why?
|
| DNA-Binding Proteins | 11 | 2024 | 9612 | 0.850 |
Why?
|
| Methylmalonic Acid | 6 | 2009 | 50 | 0.830 |
Why?
|
| Limb Deformities, Congenital | 2 | 2020 | 136 | 0.810 |
Why?
|
| Tay-Sachs Disease | 1 | 2022 | 20 | 0.790 |
Why?
|
| Glucosylceramidase | 7 | 2022 | 125 | 0.790 |
Why?
|
| alpha-Glucosidases | 4 | 2014 | 46 | 0.770 |
Why?
|
| Lysosomal Storage Diseases | 7 | 2021 | 80 | 0.750 |
Why?
|
| Infant, Newborn | 55 | 2023 | 26396 | 0.740 |
Why?
|
| Wolfram Syndrome | 1 | 2020 | 14 | 0.730 |
Why?
|
| Amidinotransferases | 2 | 2017 | 11 | 0.730 |
Why?
|
| Blood Specimen Collection | 5 | 2010 | 238 | 0.720 |
Why?
|
| Chromatography, High Pressure Liquid | 9 | 2014 | 1531 | 0.710 |
Why?
|
| Mutation | 33 | 2023 | 30211 | 0.690 |
Why?
|
| Glycolipids | 4 | 2014 | 203 | 0.690 |
Why?
|
| Holoprosencephaly | 1 | 2019 | 22 | 0.680 |
Why?
|
| Craniofacial Abnormalities | 2 | 2020 | 320 | 0.680 |
Why?
|
| Phenylketonurias | 4 | 2014 | 128 | 0.680 |
Why?
|
| Polyhydramnios | 1 | 2019 | 41 | 0.670 |
Why?
|
| Cataract | 2 | 2023 | 837 | 0.670 |
Why?
|
| Homocystinuria | 4 | 2005 | 65 | 0.660 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2020 | 131 | 0.660 |
Why?
|
| Osteosclerosis | 1 | 2019 | 41 | 0.650 |
Why?
|
| Casein Kinase I | 1 | 2019 | 46 | 0.650 |
Why?
|
| Mucopolysaccharidosis I | 3 | 2015 | 53 | 0.650 |
Why?
|
| Microcephaly | 3 | 2019 | 426 | 0.640 |
Why?
|
| Muscular Diseases | 1 | 2023 | 552 | 0.630 |
Why?
|
| Glycocalyx | 1 | 2020 | 99 | 0.630 |
Why?
|
| Exophthalmos | 1 | 2019 | 100 | 0.610 |
Why?
|
| Infant | 51 | 2023 | 36485 | 0.600 |
Why?
|
| Iduronidase | 3 | 2015 | 31 | 0.590 |
Why?
|
| Rett Syndrome | 2 | 2011 | 164 | 0.580 |
Why?
|
| Noonan Syndrome | 2 | 2015 | 122 | 0.580 |
Why?
|
| Sphingolipids | 3 | 2014 | 177 | 0.580 |
Why?
|
| Rare Diseases | 5 | 2023 | 630 | 0.570 |
Why?
|
| Arginine | 2 | 2012 | 931 | 0.570 |
Why?
|
| Child, Preschool | 49 | 2023 | 42606 | 0.560 |
Why?
|
| Alkaptonuria | 1 | 2017 | 13 | 0.560 |
Why?
|
| Cleft Palate | 2 | 2021 | 596 | 0.550 |
Why?
|
| alpha-Galactosidase | 4 | 2014 | 58 | 0.550 |
Why?
|
| Fluorometry | 2 | 2013 | 99 | 0.540 |
Why?
|
| Leucine | 7 | 2006 | 547 | 0.520 |
Why?
|
| Stomach | 1 | 2020 | 701 | 0.520 |
Why?
|
| Glycine | 6 | 2009 | 670 | 0.520 |
Why?
|
| Vitamin B 12 Deficiency | 3 | 2009 | 119 | 0.510 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 2 | 2017 | 23 | 0.510 |
Why?
|
| Color | 1 | 2017 | 296 | 0.510 |
Why?
|
| Maze Learning | 1 | 2017 | 480 | 0.500 |
Why?
|
| Fetal Growth Retardation | 1 | 2019 | 592 | 0.500 |
Why?
|
| Sphingomyelin Phosphodiesterase | 3 | 2012 | 83 | 0.500 |
Why?
|
| Urine | 1 | 2017 | 362 | 0.490 |
Why?
|
| Vitamin B 12 | 7 | 2013 | 529 | 0.490 |
Why?
|
| Genetic Association Studies | 6 | 2020 | 2744 | 0.490 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 832 | 0.480 |
Why?
|
| Mucopolysaccharidosis III | 1 | 2014 | 11 | 0.470 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2020 | 783 | 0.470 |
Why?
|
| Motor Skills | 1 | 2017 | 521 | 0.460 |
Why?
|
| Humans | 176 | 2024 | 767040 | 0.450 |
Why?
|
| Transcobalamins | 2 | 2013 | 22 | 0.450 |
Why?
|
| Epiphyses | 1 | 2014 | 191 | 0.440 |
Why?
|
| Pancreas Transplantation | 1 | 2014 | 194 | 0.440 |
Why?
|
| Osteochondrodysplasias | 1 | 2014 | 183 | 0.430 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2023 | 1854 | 0.420 |
Why?
|
| Mutation, Missense | 5 | 2019 | 2592 | 0.420 |
Why?
|
| Growth Disorders | 1 | 2017 | 635 | 0.410 |
Why?
|
| Genotype | 9 | 2023 | 13035 | 0.410 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2017 | 724 | 0.400 |
Why?
|
| Glycoproteins | 2 | 2013 | 2200 | 0.400 |
Why?
|
| Alanine | 4 | 2006 | 613 | 0.390 |
Why?
|
| Amino Acids | 3 | 2007 | 1712 | 0.390 |
Why?
|
| Blood Chemical Analysis | 2 | 2013 | 434 | 0.390 |
Why?
|
| Repressor Proteins | 2 | 2020 | 2979 | 0.380 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 2057 | 0.380 |
Why?
|
| Glucose | 9 | 2009 | 4341 | 0.380 |
Why?
|
| Language Development Disorders | 2 | 2017 | 194 | 0.370 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2004 | 172 | 0.370 |
Why?
|
| Nitric Oxide Synthase | 2 | 2012 | 911 | 0.370 |
Why?
|
| Hydroxocobalamin | 5 | 2013 | 27 | 0.360 |
Why?
|
| ras Proteins | 2 | 2015 | 1054 | 0.360 |
Why?
|
| Ear, External | 2 | 2010 | 165 | 0.350 |
Why?
|
| Enzyme Replacement Therapy | 5 | 2015 | 80 | 0.350 |
Why?
|
| Biotinidase | 1 | 2010 | 17 | 0.350 |
Why?
|
| Child | 48 | 2023 | 80771 | 0.340 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 2 | 2024 | 308 | 0.340 |
Why?
|
| Tyrosinemias | 2 | 2007 | 10 | 0.340 |
Why?
|
| Family | 1 | 2021 | 3210 | 0.340 |
Why?
|
| Enzyme Assays | 1 | 2010 | 103 | 0.340 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2024 | 699 | 0.330 |
Why?
|
| Male | 87 | 2021 | 364203 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2010 | 640 | 0.320 |
Why?
|
| Glutarates | 3 | 2015 | 242 | 0.310 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 4 | 2017 | 19 | 0.310 |
Why?
|
| Caregivers | 1 | 2021 | 2302 | 0.310 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2014 | 788 | 0.310 |
Why?
|
| Developmental Disabilities | 5 | 2020 | 1518 | 0.310 |
Why?
|
| Propionic Acidemia | 3 | 2013 | 9 | 0.300 |
Why?
|
| Mannose-Binding Lectin | 2 | 2006 | 146 | 0.300 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 1492 | 0.300 |
Why?
|
| Female | 85 | 2023 | 396660 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2014 | 3449 | 0.300 |
Why?
|
| 4-Hydroxyphenylpyruvate Dioxygenase | 1 | 2007 | 2 | 0.290 |
Why?
|
| Cyclohexenes | 1 | 2007 | 15 | 0.290 |
Why?
|
| Amino Acids, Sulfur | 1 | 2007 | 16 | 0.290 |
Why?
|
| Isotope Labeling | 3 | 1997 | 390 | 0.290 |
Why?
|
| Infertility, Male | 1 | 2011 | 396 | 0.290 |
Why?
|
| Methionine | 2 | 2007 | 570 | 0.290 |
Why?
|
| DNA Mutational Analysis | 11 | 2011 | 4114 | 0.280 |
Why?
|
| Motor Activity | 1 | 2017 | 2713 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2007 | 228 | 0.280 |
Why?
|
| Endothelial Cells | 1 | 2020 | 3582 | 0.280 |
Why?
|
| Aspartic Acid | 3 | 2010 | 575 | 0.270 |
Why?
|
| Blood Stains | 1 | 2006 | 8 | 0.270 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 3702 | 0.270 |
Why?
|
| Psychomotor Disorders | 1 | 2007 | 149 | 0.270 |
Why?
|
| Creatinine | 2 | 2009 | 1916 | 0.260 |
Why?
|
| Facial Bones | 1 | 2007 | 209 | 0.260 |
Why?
|
| Trisomy | 1 | 2007 | 260 | 0.260 |
Why?
|
| Ketosis | 1 | 2006 | 46 | 0.260 |
Why?
|
| Thrombosis | 1 | 2020 | 2954 | 0.260 |
Why?
|
| Adolescent | 38 | 2021 | 89046 | 0.250 |
Why?
|
| Orofaciodigital Syndromes | 1 | 2005 | 21 | 0.250 |
Why?
|
| Hematinics | 3 | 2005 | 282 | 0.250 |
Why?
|
| Eye Abnormalities | 2 | 2020 | 243 | 0.250 |
Why?
|
| Methyltransferases | 4 | 2004 | 373 | 0.250 |
Why?
|
| Membrane Proteins | 2 | 2020 | 7868 | 0.250 |
Why?
|
| Pedigree | 8 | 2020 | 4539 | 0.240 |
Why?
|
| Glycogen Storage Disease Type I | 2 | 2002 | 53 | 0.240 |
Why?
|
| Energy Metabolism | 7 | 2001 | 2906 | 0.240 |
Why?
|
| Chromosome Deletion | 2 | 2007 | 1384 | 0.230 |
Why?
|
| Dermatan Sulfate | 2 | 2015 | 43 | 0.230 |
Why?
|
| Isotopes | 2 | 2001 | 125 | 0.230 |
Why?
|
| Carrier Proteins | 1 | 2017 | 4925 | 0.230 |
Why?
|
| Homocysteine | 4 | 2012 | 637 | 0.230 |
Why?
|
| Liver Failure, Acute | 2 | 2017 | 182 | 0.230 |
Why?
|
| Dietary Supplements | 2 | 2011 | 3446 | 0.230 |
Why?
|
| Polymorphism, Genetic | 5 | 2011 | 4247 | 0.230 |
Why?
|
| Breath Tests | 4 | 2002 | 297 | 0.230 |
Why?
|
| Hematocrit | 3 | 2012 | 622 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 4401 | 0.220 |
Why?
|
| Myosin Type I | 1 | 2023 | 21 | 0.220 |
Why?
|
| Alleles | 8 | 2020 | 6893 | 0.210 |
Why?
|
| Betaine | 2 | 2005 | 90 | 0.210 |
Why?
|
| Heparitin Sulfate | 2 | 2015 | 223 | 0.210 |
Why?
|
| Aicardi Syndrome | 1 | 2023 | 16 | 0.210 |
Why?
|
| Chromosomes, Human, X | 1 | 2005 | 319 | 0.210 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2010 | 3684 | 0.210 |
Why?
|
| Starch | 1 | 2002 | 81 | 0.200 |
Why?
|
| Laryngismus | 1 | 2002 | 28 | 0.200 |
Why?
|
| Liver Transplantation | 1 | 2014 | 2416 | 0.200 |
Why?
|
| Neural Stem Cells | 2 | 2021 | 895 | 0.200 |
Why?
|
| Facies | 3 | 2020 | 224 | 0.200 |
Why?
|
| Iduronate Sulfatase | 3 | 2011 | 10 | 0.200 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 2 | 2017 | 46 | 0.200 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5886 | 0.200 |
Why?
|
| Osteopetrosis | 1 | 2001 | 42 | 0.190 |
Why?
|
| Milk Hypersensitivity | 1 | 2022 | 83 | 0.190 |
Why?
|
| Glycosylation | 2 | 2019 | 1099 | 0.190 |
Why?
|
| CHARGE Syndrome | 1 | 2021 | 34 | 0.190 |
Why?
|
| Genetic Testing | 6 | 2020 | 3591 | 0.190 |
Why?
|
| Sotos Syndrome | 1 | 2021 | 10 | 0.190 |
Why?
|
| Amniotic Band Syndrome | 1 | 2001 | 22 | 0.190 |
Why?
|
| Hypoglycemia | 2 | 2006 | 896 | 0.190 |
Why?
|
| Quality of Life | 2 | 2022 | 13485 | 0.190 |
Why?
|
| Heterozygote | 6 | 2020 | 2794 | 0.180 |
Why?
|
| Hydrogen | 2 | 2002 | 168 | 0.180 |
Why?
|
| Adult | 40 | 2023 | 223317 | 0.180 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2023 | 434 | 0.180 |
Why?
|
| Muscle Cells | 1 | 2021 | 194 | 0.180 |
Why?
|
| Folic Acid | 3 | 2007 | 1336 | 0.170 |
Why?
|
| Porphyria, Acute Intermittent | 1 | 2000 | 16 | 0.170 |
Why?
|
| Protein Denaturation | 2 | 2011 | 241 | 0.170 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 1965 | 0.170 |
Why?
|
| Hematoma, Subdural | 1 | 2001 | 128 | 0.170 |
Why?
|
| Fractures, Spontaneous | 1 | 2001 | 232 | 0.170 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2019 | 21 | 0.170 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2000 | 73 | 0.170 |
Why?
|
| Growth Charts | 1 | 2020 | 60 | 0.170 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 2000 | 44 | 0.170 |
Why?
|
| Genes, X-Linked | 2 | 2011 | 129 | 0.170 |
Why?
|
| Integrins | 1 | 2024 | 840 | 0.160 |
Why?
|
| Maple Syrup Urine Disease | 2 | 1997 | 41 | 0.160 |
Why?
|
| Age of Onset | 5 | 2020 | 3344 | 0.160 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 1029 | 0.160 |
Why?
|
| Phosphorylcholine | 1 | 2020 | 152 | 0.160 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 4268 | 0.160 |
Why?
|
| Dehydrocholesterols | 1 | 1999 | 20 | 0.160 |
Why?
|
| Homozygote | 3 | 2019 | 1774 | 0.160 |
Why?
|
| Premature Birth | 2 | 2014 | 1830 | 0.160 |
Why?
|
| Exons | 4 | 2011 | 2391 | 0.160 |
Why?
|
| Spasms, Infantile | 1 | 2023 | 300 | 0.160 |
Why?
|
| Smith-Lemli-Opitz Syndrome | 1 | 1999 | 46 | 0.160 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 89 | 0.160 |
Why?
|
| Oxidoreductases | 1 | 2001 | 409 | 0.150 |
Why?
|
| Lysine | 1 | 2023 | 998 | 0.150 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2019 | 134 | 0.150 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 1660 | 0.150 |
Why?
|
| Filipin | 1 | 2017 | 14 | 0.150 |
Why?
|
| Glycogen Storage Disease Type III | 1 | 1997 | 13 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 553 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 6 | 2009 | 6067 | 0.150 |
Why?
|
| Genes, Recessive | 1 | 2020 | 624 | 0.150 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.150 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2011 | 184 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 2887 | 0.140 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2002 | 396 | 0.140 |
Why?
|
| Central Nervous System Diseases | 1 | 2021 | 518 | 0.140 |
Why?
|
| T-Box Domain Proteins | 1 | 2020 | 471 | 0.140 |
Why?
|
| Gastrointestinal Agents | 1 | 2002 | 511 | 0.140 |
Why?
|
| Hydrops Fetalis | 1 | 2017 | 113 | 0.140 |
Why?
|
| Choline | 3 | 2010 | 511 | 0.140 |
Why?
|
| Brain Diseases, Metabolic | 1 | 2017 | 44 | 0.140 |
Why?
|
| Catalytic Domain | 1 | 2019 | 699 | 0.140 |
Why?
|
| High-Throughput Screening Assays | 2 | 2013 | 940 | 0.140 |
Why?
|
| Mutagenesis, Insertional | 1 | 2019 | 661 | 0.140 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2019 | 462 | 0.140 |
Why?
|
| Urinary Tract | 1 | 2020 | 305 | 0.140 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2017 | 42 | 0.140 |
Why?
|
| Deafness | 1 | 2021 | 460 | 0.130 |
Why?
|
| Plasma | 1 | 2020 | 583 | 0.130 |
Why?
|
| Syndrome | 5 | 2020 | 3271 | 0.130 |
Why?
|
| Zebrafish | 3 | 2017 | 3036 | 0.130 |
Why?
|
| Gluconeogenesis | 1 | 1997 | 186 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2020 | 772 | 0.130 |
Why?
|
| Genetic Diseases, X-Linked | 3 | 2012 | 386 | 0.130 |
Why?
|
| Mitochondrial Encephalomyopathies | 2 | 2010 | 40 | 0.130 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 355 | 0.130 |
Why?
|
| Medical History Taking | 1 | 2020 | 779 | 0.130 |
Why?
|
| Case-Control Studies | 8 | 2019 | 22254 | 0.130 |
Why?
|
| Benzeneacetamides | 1 | 2015 | 36 | 0.130 |
Why?
|
| Speech Disorders | 1 | 2017 | 178 | 0.130 |
Why?
|
| Craniosynostoses | 1 | 2020 | 415 | 0.130 |
Why?
|
| Critical Illness | 2 | 2019 | 2753 | 0.120 |
Why?
|
| Liver | 5 | 2017 | 7578 | 0.120 |
Why?
|
| Son of Sevenless Proteins | 1 | 2015 | 27 | 0.120 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 606 | 0.120 |
Why?
|
| Cleft Lip | 1 | 2021 | 512 | 0.120 |
Why?
|
| Protein Folding | 1 | 2019 | 869 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2021 | 18063 | 0.120 |
Why?
|
| Trihexosylceramides | 1 | 2014 | 29 | 0.120 |
Why?
|
| Phenylalanine | 2 | 2012 | 367 | 0.120 |
Why?
|
| Calorimetry, Indirect | 4 | 2006 | 177 | 0.120 |
Why?
|
| Young Adult | 14 | 2020 | 59980 | 0.120 |
Why?
|
| Movement Disorders | 2 | 2017 | 462 | 0.110 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 12986 | 0.110 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 1 | 2014 | 68 | 0.110 |
Why?
|
| Protein Conformation | 2 | 2015 | 3948 | 0.110 |
Why?
|
| DNA Primers | 2 | 2011 | 2827 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 3052 | 0.110 |
Why?
|
| Proteins | 2 | 2000 | 6001 | 0.110 |
Why?
|
| Specimen Handling | 2 | 2005 | 706 | 0.110 |
Why?
|
| Epilepsy | 2 | 2019 | 3317 | 0.110 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 748 | 0.110 |
Why?
|
| Cation Transport Proteins | 1 | 2016 | 325 | 0.110 |
Why?
|
| Point Mutation | 1 | 2019 | 1591 | 0.110 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 5794 | 0.110 |
Why?
|
| Manganese | 1 | 2016 | 393 | 0.110 |
Why?
|
| Lysosomes | 2 | 2021 | 937 | 0.110 |
Why?
|
| Parkinsonian Disorders | 1 | 2016 | 285 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1604 | 0.110 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 2421 | 0.110 |
Why?
|
| Austria | 3 | 2011 | 207 | 0.100 |
Why?
|
| Diet Therapy | 1 | 2014 | 150 | 0.100 |
Why?
|
| Mannosyltransferases | 1 | 2012 | 24 | 0.100 |
Why?
|
| Galactosemias | 1 | 2014 | 126 | 0.100 |
Why?
|
| Chondrosarcoma | 1 | 2015 | 305 | 0.100 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2018 | 820 | 0.100 |
Why?
|
| Metabolic Diseases | 2 | 2008 | 684 | 0.100 |
Why?
|
| N-Acetylgalactosamine-4-Sulfatase | 1 | 2012 | 2 | 0.100 |
Why?
|
| Mucopolysaccharidosis VI | 1 | 2012 | 4 | 0.100 |
Why?
|
| Neuroglia | 1 | 2018 | 960 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 1889 | 0.100 |
Why?
|
| Animals | 15 | 2024 | 168965 | 0.100 |
Why?
|
| Sphingomyelins | 1 | 2012 | 104 | 0.100 |
Why?
|
| Child Abuse | 1 | 2001 | 1090 | 0.100 |
Why?
|
| Sensitivity and Specificity | 6 | 2020 | 14672 | 0.100 |
Why?
|
| Dystonic Disorders | 1 | 2016 | 354 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2018 | 863 | 0.100 |
Why?
|
| NADH Dehydrogenase | 1 | 2011 | 47 | 0.090 |
Why?
|
| Models, Animal | 1 | 2017 | 2121 | 0.090 |
Why?
|
| Genetic Variation | 4 | 2019 | 6611 | 0.090 |
Why?
|
| Hexosaminidases | 1 | 2010 | 45 | 0.090 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 1444 | 0.090 |
Why?
|
| Reference Standards | 2 | 2012 | 1011 | 0.090 |
Why?
|
| Glucosylceramides | 1 | 2010 | 27 | 0.090 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2010 | 55 | 0.090 |
Why?
|
| Metabolomics | 1 | 2020 | 1675 | 0.090 |
Why?
|
| Pregnancy | 7 | 2019 | 30238 | 0.090 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 927 | 0.090 |
Why?
|
| Enzyme Stability | 1 | 2010 | 218 | 0.090 |
Why?
|
| Fibroblast Growth Factor 3 | 1 | 2010 | 17 | 0.090 |
Why?
|
| Astrocytes | 1 | 2018 | 1352 | 0.090 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 1562 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2020 | 1239 | 0.090 |
Why?
|
| Gene Expression | 2 | 2015 | 7587 | 0.090 |
Why?
|
| Oxidative Stress | 2 | 2012 | 3139 | 0.080 |
Why?
|
| Electron Transport Complex I | 1 | 2011 | 152 | 0.080 |
Why?
|
| Indicators and Reagents | 1 | 2011 | 456 | 0.080 |
Why?
|
| Tooth Abnormalities | 1 | 2010 | 56 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 3726 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 2 | 2020 | 1626 | 0.080 |
Why?
|
| Galactosyltransferases | 1 | 2011 | 283 | 0.080 |
Why?
|
| X Chromosome Inactivation | 1 | 2012 | 229 | 0.080 |
Why?
|
| Glycogen Storage Disease Type IIb | 1 | 2009 | 18 | 0.080 |
Why?
|
| Methylmalonyl-CoA Mutase | 1 | 2009 | 23 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3828 | 0.080 |
Why?
|
| DNA | 3 | 2011 | 7210 | 0.080 |
Why?
|
| Nucleic Acid Denaturation | 2 | 2009 | 111 | 0.080 |
Why?
|
| Imidazoles | 1 | 2015 | 1169 | 0.080 |
Why?
|
| Chemokines, CC | 1 | 2010 | 286 | 0.080 |
Why?
|
| Muscle Hypotonia | 2 | 2018 | 166 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2021 | 11657 | 0.080 |
Why?
|
| Glucosidases | 1 | 2008 | 12 | 0.080 |
Why?
|
| Liver, Artificial | 1 | 2009 | 55 | 0.080 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 951 | 0.080 |
Why?
|
| Inositol | 1 | 2010 | 216 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2019 | 12158 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 1293 | 0.080 |
Why?
|
| Computational Biology | 2 | 2019 | 3567 | 0.080 |
Why?
|
| Retrospective Studies | 10 | 2023 | 81659 | 0.080 |
Why?
|
| Glycosaminoglycans | 1 | 2012 | 611 | 0.080 |
Why?
|
| Heparin Cofactor II | 1 | 2008 | 3 | 0.080 |
Why?
|
| Renal Insufficiency | 1 | 2014 | 812 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2024 | 14476 | 0.080 |
Why?
|
| Lymphedema | 1 | 2015 | 526 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4572 | 0.080 |
Why?
|
| Mucopolysaccharidoses | 1 | 2008 | 27 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1750 | 0.080 |
Why?
|
| Research | 1 | 1997 | 1977 | 0.080 |
Why?
|
| Pancytopenia | 1 | 2009 | 102 | 0.080 |
Why?
|
| Glucan 1,4-alpha-Glucosidase | 1 | 2007 | 8 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 3610 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 1119 | 0.070 |
Why?
|
| Asymptomatic Diseases | 1 | 2011 | 588 | 0.070 |
Why?
|
| Haploinsufficiency | 2 | 2020 | 334 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2020 | 4424 | 0.070 |
Why?
|
| Genetic Markers | 2 | 2012 | 2602 | 0.070 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2886 | 0.070 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2007 | 111 | 0.070 |
Why?
|
| Acids | 1 | 2008 | 125 | 0.070 |
Why?
|
| Leukocytes | 2 | 2013 | 2034 | 0.070 |
Why?
|
| Infertility | 1 | 2014 | 655 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3797 | 0.070 |
Why?
|
| Carbon Dioxide | 2 | 2002 | 1137 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2015 | 1217 | 0.070 |
Why?
|
| Protein Binding | 1 | 2019 | 9327 | 0.070 |
Why?
|
| Intestinal Diseases | 1 | 2011 | 505 | 0.070 |
Why?
|
| Furans | 1 | 2008 | 199 | 0.070 |
Why?
|
| Vitamin B 6 | 1 | 2008 | 237 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 10254 | 0.070 |
Why?
|
| Acetates | 1 | 2008 | 314 | 0.070 |
Why?
|
| Amino Acid Substitution | 2 | 2019 | 1743 | 0.070 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2007 | 167 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 267 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2024 | 11923 | 0.060 |
Why?
|
| Lipoproteins, HDL | 1 | 2010 | 679 | 0.060 |
Why?
|
| Pediatrics | 1 | 2001 | 3621 | 0.060 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2006 | 98 | 0.060 |
Why?
|
| Ear, Inner | 1 | 2010 | 426 | 0.060 |
Why?
|
| Nucleic Acid Heteroduplexes | 1 | 2005 | 46 | 0.060 |
Why?
|
| Brain | 5 | 2018 | 27163 | 0.060 |
Why?
|
| Mice | 8 | 2024 | 81912 | 0.060 |
Why?
|
| Urinalysis | 1 | 2008 | 369 | 0.060 |
Why?
|
| Thrombin | 1 | 2008 | 600 | 0.060 |
Why?
|
| Prenatal Diagnosis | 2 | 2010 | 1271 | 0.060 |
Why?
|
| Risk Factors | 5 | 2020 | 74886 | 0.060 |
Why?
|
| HELLP Syndrome | 1 | 2005 | 41 | 0.060 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2005 | 59 | 0.060 |
Why?
|
| Homeostasis | 1 | 2016 | 3345 | 0.060 |
Why?
|
| Infant, Premature | 3 | 2000 | 2125 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2011 | 2105 | 0.060 |
Why?
|
| Basal Metabolism | 1 | 2006 | 163 | 0.060 |
Why?
|
| Codon | 1 | 2006 | 599 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 6507 | 0.060 |
Why?
|
| Methylation | 1 | 2007 | 1076 | 0.060 |
Why?
|
| Europe | 2 | 2010 | 3432 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2010 | 980 | 0.060 |
Why?
|
| Ketone Bodies | 1 | 2004 | 76 | 0.060 |
Why?
|
| Hemoglobins | 1 | 2010 | 1531 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2024 | 23621 | 0.060 |
Why?
|
| Sex Factors | 2 | 2010 | 10622 | 0.050 |
Why?
|
| Sudden Infant Death | 1 | 2006 | 293 | 0.050 |
Why?
|
| Nitrobenzoates | 1 | 2003 | 17 | 0.050 |
Why?
|
| Treatment Outcome | 9 | 2020 | 65295 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 4 | 2014 | 7435 | 0.050 |
Why?
|
| Cyclohexanones | 1 | 2003 | 30 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 1895 | 0.050 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2006 | 267 | 0.050 |
Why?
|
| Paresthesia | 1 | 2004 | 160 | 0.050 |
Why?
|
| Toes | 1 | 2004 | 209 | 0.050 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2004 | 209 | 0.050 |
Why?
|
| Kinetics | 3 | 2000 | 6287 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15925 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2012 | 1836 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2012 | 2140 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2011 | 1304 | 0.050 |
Why?
|
| Myotonic Disorders | 1 | 2002 | 7 | 0.050 |
Why?
|
| Florida | 2 | 2014 | 417 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 18330 | 0.050 |
Why?
|
| Vigabatrin | 1 | 2023 | 88 | 0.050 |
Why?
|
| Fasting | 2 | 2006 | 1607 | 0.050 |
Why?
|
| Germany | 2 | 2011 | 882 | 0.050 |
Why?
|
| Milk Proteins | 1 | 2022 | 161 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2010 | 20169 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2009 | 1247 | 0.050 |
Why?
|
| Liver Regeneration | 1 | 2003 | 214 | 0.050 |
Why?
|
| Meglutol | 1 | 2001 | 5 | 0.050 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 2001 | 74 | 0.050 |
Why?
|
| Insulin | 3 | 2006 | 6602 | 0.050 |
Why?
|
| Fingers | 1 | 2004 | 508 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2002 | 322 | 0.050 |
Why?
|
| Ilium | 1 | 2001 | 155 | 0.050 |
Why?
|
| Diet, Protein-Restricted | 1 | 2001 | 73 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2001 | 120 | 0.040 |
Why?
|
| Base Sequence | 3 | 2009 | 12414 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2002 | 551 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2002 | 341 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 1997 | 2221 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2002 | 451 | 0.040 |
Why?
|
| Biopsy | 3 | 2019 | 6777 | 0.040 |
Why?
|
| Nutrition Disorders | 1 | 2001 | 204 | 0.040 |
Why?
|
| Blood Glucose | 3 | 2012 | 6421 | 0.040 |
Why?
|
| Brain Chemistry | 1 | 2004 | 951 | 0.040 |
Why?
|
| Chromosome Aberrations | 2 | 2007 | 1776 | 0.040 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2022 | 352 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2002 | 492 | 0.040 |
Why?
|
| Administration, Sublingual | 1 | 1999 | 60 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 26325 | 0.040 |
Why?
|
| Milk | 1 | 2022 | 437 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2000 | 6873 | 0.040 |
Why?
|
| Autoimmune Diseases | 1 | 2012 | 2255 | 0.040 |
Why?
|
| Minerals | 1 | 2001 | 279 | 0.040 |
Why?
|
| Propionates | 1 | 2000 | 180 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2006 | 1361 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2006 | 3621 | 0.040 |
Why?
|
| Diet | 1 | 2017 | 8089 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2023 | 36582 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2010 | 1931 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2009 | 1861 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2021 | 399 | 0.040 |
Why?
|
| Dementia, Vascular | 1 | 2000 | 126 | 0.040 |
Why?
|
| Middle Aged | 11 | 2020 | 223233 | 0.040 |
Why?
|
| Cats | 1 | 2020 | 972 | 0.040 |
Why?
|
| Mass Screening | 1 | 2014 | 5456 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2000 | 534 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 1559 | 0.040 |
Why?
|
| Fructose Intolerance | 1 | 1997 | 8 | 0.040 |
Why?
|
| Mass Spectrometry | 2 | 2005 | 2201 | 0.040 |
Why?
|
| Deuterium Oxide | 1 | 1997 | 34 | 0.040 |
Why?
|
| Seizures | 2 | 2019 | 2996 | 0.040 |
Why?
|
| Disease Progression | 3 | 2011 | 13646 | 0.040 |
Why?
|
| Software | 1 | 2012 | 4472 | 0.040 |
Why?
|
| Oxygen Isotopes | 1 | 1997 | 41 | 0.040 |
Why?
|
| Quality Control | 2 | 2012 | 835 | 0.040 |
Why?
|
| Glycogen Storage Disease | 1 | 1997 | 41 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2017 | 746 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 309 | 0.040 |
Why?
|
| Drugs, Investigational | 1 | 2019 | 211 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2000 | 409 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 9551 | 0.040 |
Why?
|
| Disease Management | 3 | 2014 | 2531 | 0.040 |
Why?
|
| Family Health | 1 | 2002 | 1254 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 447 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2007 | 5388 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12451 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2011 | 4426 | 0.030 |
Why?
|
| Linear Models | 1 | 2007 | 5875 | 0.030 |
Why?
|
| Models, Biological | 2 | 2007 | 9464 | 0.030 |
Why?
|
| Fever | 1 | 2004 | 1605 | 0.030 |
Why?
|
| Respiratory Tract Infections | 1 | 2004 | 1009 | 0.030 |
Why?
|
| Cerebellum | 1 | 2023 | 1521 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 1998 | 385 | 0.030 |
Why?
|
| Neocortex | 1 | 2020 | 414 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2021 | 854 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2020 | 996 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2004 | 1806 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2012 | 3418 | 0.030 |
Why?
|
| Introns | 2 | 2011 | 965 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2001 | 872 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 2002 | 766 | 0.030 |
Why?
|
| Cohort Studies | 5 | 2020 | 41718 | 0.030 |
Why?
|
| Basal Ganglia | 1 | 2018 | 549 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 328 | 0.030 |
Why?
|
| alpha-Synuclein | 1 | 2022 | 773 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 1029 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2018 | 807 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 5796 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1997 | 393 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2002 | 4026 | 0.030 |
Why?
|
| Fish Oils | 1 | 1998 | 483 | 0.030 |
Why?
|
| Genetics, Medical | 1 | 2017 | 334 | 0.030 |
Why?
|
| Age Distribution | 2 | 2010 | 2870 | 0.030 |
Why?
|
| Reference Values | 1 | 2001 | 4918 | 0.030 |
Why?
|
| Cell Line | 2 | 2010 | 15567 | 0.030 |
Why?
|
| Autophagy | 1 | 2021 | 1347 | 0.030 |
Why?
|
| Dystonia | 1 | 2017 | 378 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2014 | 171 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 16036 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2024 | 5499 | 0.030 |
Why?
|
| Lipoproteins | 1 | 1998 | 871 | 0.030 |
Why?
|
| Finland | 1 | 2014 | 608 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1103 | 0.030 |
Why?
|
| Neural Conduction | 1 | 2014 | 442 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2023 | 1921 | 0.030 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2013 | 115 | 0.030 |
Why?
|
| Prenatal Care | 2 | 2014 | 1158 | 0.030 |
Why?
|
| Antigens | 1 | 2018 | 1442 | 0.030 |
Why?
|
| Galactose | 1 | 2014 | 299 | 0.030 |
Why?
|
| Niemann-Pick Diseases | 1 | 2012 | 27 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2003 | 1959 | 0.030 |
Why?
|
| Drosophila | 1 | 2020 | 1509 | 0.030 |
Why?
|
| Galactosylceramidase | 1 | 2012 | 22 | 0.030 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2012 | 15 | 0.020 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2012 | 38 | 0.020 |
Why?
|
| Cephalometry | 1 | 2013 | 380 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2019 | 2668 | 0.020 |
Why?
|
| Aging | 2 | 2009 | 8729 | 0.020 |
Why?
|
| Retina | 1 | 2023 | 2659 | 0.020 |
Why?
|
| Placenta Diseases | 1 | 2014 | 199 | 0.020 |
Why?
|
| Recurrence | 1 | 2004 | 8504 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2019 | 1068 | 0.020 |
Why?
|
| Lactation | 1 | 2014 | 392 | 0.020 |
Why?
|
| Body Composition | 1 | 2001 | 2454 | 0.020 |
Why?
|
| Data Collection | 2 | 2010 | 3321 | 0.020 |
Why?
|
| Minnesota | 1 | 2012 | 339 | 0.020 |
Why?
|
| Glutathione | 1 | 2014 | 589 | 0.020 |
Why?
|
| Aged | 8 | 2020 | 171319 | 0.020 |
Why?
|
| Switzerland | 1 | 2011 | 322 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2020 | 1722 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2019 | 12793 | 0.020 |
Why?
|
| Health Expenditures | 1 | 2023 | 2390 | 0.020 |
Why?
|
| Prognosis | 2 | 2009 | 29963 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2011 | 504 | 0.020 |
Why?
|
| Health Planning Organizations | 1 | 2010 | 13 | 0.020 |
Why?
|
| Career Choice | 1 | 1997 | 769 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2019 | 54886 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 5537 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 793 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2015 | 799 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2017 | 1396 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2015 | 1244 | 0.020 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2010 | 54 | 0.020 |
Why?
|
| Cobamides | 1 | 2009 | 12 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 14098 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2009 | 53 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2012 | 959 | 0.020 |
Why?
|
| Hypospadias | 1 | 2010 | 98 | 0.020 |
Why?
|
| Hemoglobinopathies | 1 | 2010 | 101 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1188 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2010 | 152 | 0.020 |
Why?
|
| Demography | 1 | 2014 | 1641 | 0.020 |
Why?
|
| Cryptorchidism | 1 | 2010 | 153 | 0.020 |
Why?
|
| Hyperammonemia | 1 | 2010 | 80 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2018 | 2575 | 0.020 |
Why?
|
| Cognition | 2 | 2020 | 7059 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2005 | 5754 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2009 | 238 | 0.020 |
Why?
|
| Consensus | 1 | 2018 | 3207 | 0.020 |
Why?
|
| Vitamin B Deficiency | 1 | 2008 | 12 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2009 | 411 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 287 | 0.020 |
Why?
|
| Child Development | 1 | 2019 | 2329 | 0.020 |
Why?
|
| Carboxylic Acids | 1 | 2008 | 91 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2011 | 1227 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2009 | 392 | 0.020 |
Why?
|
| Hyperhomocysteinemia | 1 | 2008 | 117 | 0.020 |
Why?
|
| Cell Size | 1 | 2009 | 624 | 0.020 |
Why?
|
| Dextrans | 1 | 2009 | 574 | 0.020 |
Why?
|
| Hippocampus | 1 | 2020 | 3777 | 0.020 |
Why?
|
| Ions | 1 | 2008 | 254 | 0.020 |
Why?
|
| Metalloproteins | 1 | 2007 | 98 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2008 | 211 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4280 | 0.020 |
Why?
|
| Czech Republic | 1 | 2006 | 75 | 0.020 |
Why?
|
| Urea | 1 | 2009 | 448 | 0.020 |
Why?
|
| Solvents | 1 | 2008 | 298 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 7121 | 0.020 |
Why?
|
| Albumins | 1 | 2009 | 577 | 0.020 |
Why?
|
| Lipotropic Agents | 1 | 2005 | 13 | 0.020 |
Why?
|
| Microspheres | 1 | 2009 | 774 | 0.020 |
Why?
|
| Urban Population | 1 | 2014 | 2044 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15645 | 0.020 |
Why?
|
| Skin | 1 | 2019 | 4499 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2012 | 987 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 22361 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 5363 | 0.020 |
Why?
|
| International Cooperation | 1 | 2012 | 1434 | 0.020 |
Why?
|
| Research Design | 1 | 2001 | 6210 | 0.020 |
Why?
|
| Time Factors | 1 | 2007 | 40154 | 0.020 |
Why?
|
| Cell Count | 1 | 2009 | 1825 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2009 | 1494 | 0.010 |
Why?
|
| Placenta | 1 | 2014 | 1726 | 0.010 |
Why?
|
| Food, Formulated | 1 | 2005 | 103 | 0.010 |
Why?
|
| Metabolome | 1 | 2012 | 1008 | 0.010 |
Why?
|
| Kidney | 1 | 2020 | 7063 | 0.010 |
Why?
|
| Pre-Eclampsia | 1 | 2014 | 1255 | 0.010 |
Why?
|
| Insulin Antibodies | 1 | 2004 | 28 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2013 | 1886 | 0.010 |
Why?
|
| Lateral Ventricles | 1 | 2005 | 142 | 0.010 |
Why?
|
| Diabetes, Gestational | 1 | 2014 | 1263 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2014 | 59548 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2007 | 518 | 0.010 |
Why?
|
| Deficiency Diseases | 1 | 2004 | 74 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2019 | 6282 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 8048 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2011 | 2605 | 0.010 |
Why?
|
| Clone Cells | 1 | 2007 | 1669 | 0.010 |
Why?
|
| Outpatients | 1 | 2011 | 1600 | 0.010 |
Why?
|
| Students, Medical | 1 | 1997 | 1965 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1969 | 0.010 |
Why?
|
| S-Adenosylhomocysteine | 1 | 2003 | 40 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2227 | 0.010 |
Why?
|
| Incidence | 1 | 2001 | 21526 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2004 | 271 | 0.010 |
Why?
|
| Calibration | 1 | 2005 | 817 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2004 | 562 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 2698 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3700 | 0.010 |
Why?
|
| Glucagon | 1 | 2004 | 534 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1646 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 1377 | 0.010 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2004 | 384 | 0.010 |
Why?
|
| S-Adenosylmethionine | 1 | 2003 | 219 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2007 | 1144 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3804 | 0.010 |
Why?
|
| Genomics | 1 | 2017 | 5924 | 0.010 |
Why?
|
| Muscle, Skeletal | 2 | 2009 | 4968 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2001 | 775 | 0.010 |
Why?
|
| Monosomy | 1 | 2000 | 52 | 0.010 |
Why?
|
| Karyotyping | 1 | 2002 | 1176 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 2000 | 261 | 0.010 |
Why?
|
| Atrophy | 1 | 2005 | 1631 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2004 | 839 | 0.010 |
Why?
|
| Body Constitution | 1 | 2000 | 273 | 0.010 |
Why?
|
| Capnography | 1 | 2000 | 90 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 1729 | 0.010 |
Why?
|
| Protein Precursors | 1 | 2004 | 1134 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 2000 | 453 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2005 | 951 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9513 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2011 | 4209 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8732 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 17097 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12069 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 13411 | 0.010 |
Why?
|
| Apolipoprotein B-100 | 1 | 1998 | 157 | 0.010 |
Why?
|
| Remission Induction | 1 | 2003 | 2408 | 0.010 |
Why?
|
| Lipoproteins, VLDL | 1 | 1998 | 198 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2902 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 10092 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 17608 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 1391 | 0.010 |
Why?
|
| Myocardium | 1 | 2009 | 4765 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2012 | 8068 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1998 | 393 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2002 | 2509 | 0.010 |
Why?
|
| Body Mass Index | 2 | 2008 | 13048 | 0.010 |
Why?
|
| Lipase | 1 | 1998 | 320 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2009 | 3305 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 15424 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2004 | 2114 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2007 | 4522 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2007 | 4052 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 5716 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 24299 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 8310 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 14766 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2005 | 3968 | 0.010 |
Why?
|
| Triglycerides | 1 | 1998 | 2444 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2000 | 3445 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 15851 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2000 | 5311 | 0.000 |
Why?
|
| Respiration, Artificial | 1 | 2000 | 2726 | 0.000 |
Why?
|
| United States | 1 | 2014 | 72971 | 0.000 |
Why?
|